zae serotype b (Hib) conjugate vaccine has been a major step in the prevention of meningitis, epiglottitis, and other mani-festations of invasive Hib disease. Because these diseases occur mainly in children, vaccination during infancy prevents the vast majority of cases within a few years. The optimal schedule for Hib vaccination is still a matter of debate. In the United Kingdom, one of the first countries to im-plement Hib conjugate vaccination in the infant immunization program (in 1992), a vaccine scheme of 3 doses at 2, 3, and 4 months of age was initially applied. To-gether with a catch-up campaign, thi
Background: Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
In 1993, a Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in the Dutch nat...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Haemophilus influenzae type b (Hib) conjugate vaccines have proved extremely efficacious in healthy ...
Haemophilus influenzae type b (Hib) conjugate vaccines have proved extremely efficacious in healthy ...
Haemophilus influenzae type b (Hib) conjugate vaccines are extremely effective in protecting infants...
AbstractThe present study describes the clinical and immunological features of children with Hib vac...
In October 1992, Haemophilus influenzae type b (Hib) conjugate vaccine was introduced to infants in ...
Background: Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Background. Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
BACKGROUND: It is not known how long children with Haemophilus influenzae serotype b (Hib) vaccine f...
Prior to routine immunisation, Haemophilus influenzae serotype b (Hib) was a major cause of serious ...
Background: Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
In 1993, a Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in the Dutch nat...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Haemophilus influenzae type b (Hib) conjugate vaccines have proved extremely efficacious in healthy ...
Haemophilus influenzae type b (Hib) conjugate vaccines have proved extremely efficacious in healthy ...
Haemophilus influenzae type b (Hib) conjugate vaccines are extremely effective in protecting infants...
AbstractThe present study describes the clinical and immunological features of children with Hib vac...
In October 1992, Haemophilus influenzae type b (Hib) conjugate vaccine was introduced to infants in ...
Background: Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
Background. Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...
BACKGROUND: It is not known how long children with Haemophilus influenzae serotype b (Hib) vaccine f...
Prior to routine immunisation, Haemophilus influenzae serotype b (Hib) was a major cause of serious ...
Background: Despite the excellent immunogenicity of Haemophilus influenzae type b (Hib) conjugate va...
In 1993, a Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in the Dutch nat...
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in ...